129 related articles for article (PubMed ID: 36018060)
1. Antiviral prophylaxis, male sex, and killer immunoglobulin-like receptor KIR2DL3 as markers for stratifying the risk of BK polyomavirus-associated nephropathy in kidney transplant recipients.
Dęborska-Materkowska D; Perkowska-Ptasinska A; Sadowska-Jakubowicz A; Pazik J; Serwańska-Świętek M; Mikołajczyk N; Świder R; Nowak J; Durlik M
Pol Arch Intern Med; 2023 Jan; 133(1):. PubMed ID: 36018060
[TBL] [Abstract][Full Text] [Related]
2. BK Polyomavirus-associated nephropathy managed by screening policy in a real-life setting.
Raupp FVV; Meinerz G; da Silva CK; Bianco PCD; Goldani JC; Pegas KL; Stolfo JB; Garcia VD; Keitel E
Transpl Infect Dis; 2020 Feb; 22(1):e13213. PubMed ID: 31724282
[TBL] [Abstract][Full Text] [Related]
3. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
[TBL] [Abstract][Full Text] [Related]
4. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
[TBL] [Abstract][Full Text] [Related]
5. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
[TBL] [Abstract][Full Text] [Related]
6. BK polyomavirus microRNA expression and sequence variation in polyomavirus-associated nephropathy.
Virtanen E; Seppälä H; Helanterä I; Laine P; Lautenschlager I; Paulin L; Mannonen L; Auvinen P; Auvinen E
J Clin Virol; 2018 May; 102():70-76. PubMed ID: 29518695
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Banff Working Group classification of definitive BK polyomavirus nephropathy.
Kowalewska J; El Moudden I; Perkowska-Ptasinska A; Kapp ME; Fogo AB; Lin MY; Mirza A; Troyer DA; Durlik M; Sandhu R; Ciszek M; Deborska-Materkowska D; Kuczynski D; McCune TR
Transpl Int; 2021 Nov; 34(11):2286-2296. PubMed ID: 34339576
[TBL] [Abstract][Full Text] [Related]
8. Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska-Jakubowicz A; Gozdowska J; Ciszek M; Pazik J; Ostaszewska A; Kosieradzki M; Nowak J; Durlik M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696053
[TBL] [Abstract][Full Text] [Related]
9. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
10. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
11. Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.
Teutsch K; Schweitzer F; Knops E; Kaiser R; Pfister H; Verheyen J; Göbel H; Cingöz T; Di Cristanziano V
Med Microbiol Immunol; 2015 Dec; 204(6):657-64. PubMed ID: 25749892
[TBL] [Abstract][Full Text] [Related]
12. HLA-G 3' untranslated region gene variants are promising prognostic factors for BK polyomavirus replication and acute rejection after living-donor kidney transplant.
Rohn H; Schwich E; Tomoya Michita R; Schramm S; Dolff S; Gäckler A; Korth J; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
Hum Immunol; 2020 Apr; 81(4):141-146. PubMed ID: 31679637
[TBL] [Abstract][Full Text] [Related]
13. The Role of HLA and KIR Immunogenetics in BK Virus Infection after Kidney Transplantation.
Burek Kamenaric M; Ivkovic V; Kovacevic Vojtusek I; Zunec R
Viruses; 2020 Dec; 12(12):. PubMed ID: 33317205
[TBL] [Abstract][Full Text] [Related]
14. HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.
Rohn H; Michita RT; Schramm S; Dolff S; Gäckler A; Korth J; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
Cells; 2019 Aug; 8(8):. PubMed ID: 31394776
[TBL] [Abstract][Full Text] [Related]
15. Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients.
Kovacevic Vojtusek I; Burek Kamenaric M; Ivkovic V; Bulimbasic S; Marekovic I; Coric M; Bosnjak Z; Grubic Z; Zunec R
HLA; 2019 Dec; 94 Suppl 2():4-10. PubMed ID: 31361395
[TBL] [Abstract][Full Text] [Related]
16. The association between killer-cell immunoglobulin-like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.
Brochot E; Desoutter J; Presne C; De Araujo I; Flahaut G; Castelain S; Westeel PF; Choukroun G; Guillaume N
Transpl Int; 2016 Nov; 29(11):1168-1175. PubMed ID: 27516136
[TBL] [Abstract][Full Text] [Related]
17. Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
Hainley LE; Hughson MS; Narendran A; Smith R; Arthur J; Hayner-Buchan A; Conti DJ; Lehman JM; Friedrich TD
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372559
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
19. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
20. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
